36C24523Q0027_2.docx

This amendment to a solicitation extends the response date for solicitation number 36C24523Q0027 to September 22, 2022 at 4:00 PM Eastern Time. The solicitation is for the provision of radiopharmaceuticals to the Nuclear Medicine Section of the Radiology Service at the Department of Veterans Affairs Medical Center in Washington, D.C. over a base year and four option years. Required radiopharmaceuticals include F-18 FDG, F-18 NAF, Ga-67 gallium citrate, I-123 iobenguane sulfate, I-131 NAI capsules and solutions, In-111 pentetreotide, In-111 WBC, Mebrofenin, oxidronate, pentetate, sincalide solution and vials, Tc-99m radiopharmaceuticals, Tl-201 thallous chloride, Ra-223 dichloride, Ga-68 radiopharmaceuticals, and Cu-64 DetectNet. Delivery requirements, emergency order provisions, standing bulk Tc-99m orders, training obligations, and interface with the Nuclear Medicine Management System are also outlined. Pricing must be provided for all items for the base year and each option year. Invoices are to be submitted monthly listing services rendered.